Rahul B. Sangal
Expertise in
13
conditions

Dr. Rahul B. Sangal

Psychiatry | Neurology | Sleep Medicine
44344 Dequindre Road, Suite 360, 
Sterling Heights, MI 
On Staff At
Accepting New Patients
Offers Telehealth
48 Years of Experience
Expertise in
13
conditions
44344 Dequindre Road, Suite 360, 
Sterling Heights, MI 

Overview

Rahul Sangal is a Psychiatrist and a Neurologist in Sterling Heights, Michigan. Dr. Sangal has been practicing medicine for over 48 years is highly rated in 13 conditions, according to our data. His top areas of expertise are Excessive Daytime Sleepiness, Obstructive Sleep Apnea, Drowsiness, and Narcolepsy. Dr. Sangal is currently accepting new patients.

His clinical research consists of participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution

All-India Institute Of Medical Sciences, 1978

Residency

Johns Hopkins Hospital

Specialties

Psychiatry
Neurology
Sleep Medicine

Licenses

Psychiatry & Neurology in MI

Board Certifications

American Board Of Psychiatry And Neurology
American Board Of Psychiatry And Neurology
American Board Of Psychiatry And Neurology

Fellowships

Johns Hopkins Hospital

Hospital Affiliations

Corewell Health Beaumont Troy Hospital

Languages Spoken

English
Hindi

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Sleep & Attention Disorders Institute
44344 Dequindre Road, Suite 360, Sterling Heights, MI 48314

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
A Phase 3, Randomized, Double-blind, Multicenter, Parallel-group, Placebo-controlled, Fixed-Dose Safety and Efficacy Study of SPD489 Compared With Placebo in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Drug
Study Phase: Phase 3
A 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
A 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
Enrollment Status: Completed
Publish Date: January 09, 2020
Intervention Type: Drug, Other
Study Phase: Phase 2
View 3 Less Clinical Trials
Similar Doctors
Ronald D. Chervin
Expertise in
10
conditions
Dr. Ronald D. Chervin
Sleep Medicine | Neurology
Expertise in
10
conditions
Dr. Ronald D. Chervin
Sleep Medicine | Neurology

Regents Of The University Of Michigan

24 Frank Lloyd Wright Dr, Umhs Domino Farms, 
Ann Arbor, MI 
 (36.6 miles away)
734-936-4500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ronald Chervin is a Sleep Medicine specialist and a Neurologist in Ann Arbor, Michigan. Dr. Chervin is highly rated in 10 conditions, according to our data. His top areas of expertise are Obstructive Sleep Apnea, Restless Legs Syndrome, Central Sleep Apnea, Drowsiness, and Adenoidectomy. Dr. Chervin is currently accepting new patients.

Expertise in
24
conditions
Dr. Tobias Walbert
Neurology
Expertise in
24
conditions
Dr. Tobias Walbert
Neurology

Henry Ford Cancer-Detroit

2800 W Grand Blvd, 
Detroit, MI 
 (17.4 miles away)
888-777-4167
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tobias Walbert is a Neurologist in Detroit, Michigan. Dr. Walbert is highly rated in 24 conditions, according to our data. His top areas of expertise are Glioma, Brain Tumor, Glioblastoma, and Astrocytoma.

Expertise in
32
conditions
Dr. Narayan P. Verma
Neurology | Sleep Medicine
Expertise in
32
conditions
Dr. Narayan P. Verma
Neurology | Sleep Medicine

BG Tricounty Neurology And Sleep Clinic, PC

31150 Hoover Road, Suite B, 
Warren, MI 
 (8.0 miles away)
586-983-3666
Experience:
50+ years
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Narayan Verma is a Neurologist and a Sleep Medicine provider in Warren, Michigan. Dr. Verma has been practicing medicine for over 50 years is highly rated in 32 conditions, according to our data. His top areas of expertise are Narcolepsy, Seizures, Generalized Tonic-Clonic Seizure, and Memory Loss. Dr. Verma is currently accepting new patients.

Frequently Asked Questions about Dr. Rahul B. Sangal

How do I make an appointment with Dr. Rahul B. Sangal?

You can book an appointment with Dr. Rahul B. Sangal by calling their office at 586-254-0707. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rahul B. Sangal a top-rated expert for Excessive Daytime Sleepiness?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rahul B. Sangal is classified as an Distinguished expert for Excessive Daytime Sleepiness, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rahul B. Sangal specialize in?

While Dr. Rahul B. Sangal is a Psychiatry, they have specific expertise in Excessive Daytime Sleepiness, Obstructive Sleep Apnea, and Drowsiness. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Rahul B. Sangal accept my insurance?

Dr. Rahul B. Sangal accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 586-254-0707 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sangal's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile